Tetra Bio Pharma Inc. | Income Statement
Fiscal year is December-November. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
2.40
-
-
-
7.20
74.80
Gross Income
2.40
-
-
-
7.20
37.50
SG&A Expense
153.80
310.20
516.70
1,037.10
6,222.80
11,621.70
EBIT
156.20
310.20
516.70
1,037.10
6,396.80
11,926.30
Unusual Expense
1,955.10
104.10
132.00
13.90
282.70
-
Non Operating Income/Expense
0.00
0.00
49.80
1.70
16.30
3,960.70
Pretax Income
2,109.40
414.10
594.80
997.00
6,695.30
7,851.50
Consolidated Net Income
2,109.40
414.10
594.80
997.00
6,695.30
7,851.50
Net Income
2,109.40
414.10
594.80
944.30
6,225.30
7,572.60
Net Income After Extraordinaries
2,109.40
414.10
594.80
944.30
6,225.30
7,572.60
Net Income Available to Common
2,109.40
414.10
594.80
944.30
6,225.30
7,572.60
EPS (Basic)
0.08
0.01
0.01
0.01
0.06
0.05
Basic Shares Outstanding
26,250.50
28,520.60
55,466.80
64,807.10
107,795.40
145,686.30
EPS (Diluted)
0.08
0.01
0.01
0.01
0.06
0.05
Diluted Shares Outstanding
26,250.50
28,520.60
55,466.80
64,807.10
107,795.40
145,686.30
EBITDA
156.20
310.20
516.70
1,037.10
6,389.60
11,919.10
Other Operating Expense
-
-
-
-
166.80
342
Non-Operating Interest Income
1.90
0.20
4.10
55.80
0.50
114
Minority Interest Expense
-
-
-
52.70
470.00
279
About Tetra Bio Pharma
View Profile
